Pathogen Reduction/Inactivation of Products for the Treatment of Bleeding Disorders: What Are the Processes and What Should We Say to Patients?

Annals of Hematology- Germany

doi 10.1007/s00277-017-3028-4

Full Text

Abstract

Available in

Categories

Date

June 18, 2017

Authors

Giovanni Di Minno

Carlo Federico Perno

James W. Ironside

Hermann Eichler

Publisher

Springer Science and Business Media LLC

Related search

What We Say and How We Say It…

Journal of Family Planning and Reproductive Health Care

English

Mild Bleeding Disorders: What Every Clinician Should Know

British journal of hospital medicine (London, England : 2005)

English

Pitheciid Vocal Communication: What Can We Say About What They Are Saying?

Ethnobiology and Conservation

Landscape Conservation

English

Must We Know What We Say?

The Philosophical Review

English

A Review of Recent Data in the Treatment of Gallbladder Cancer: What We Know, What We Do, and What Should Be Done

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting

English

We Are What We Collect, We Collect What We Are: Archives and the Construction of Identity

American Archivist

Information Sciences

English

What Patients Say, What Doctors Hear

Family Medicine

Family Practice

English

The Industry Premium: What We Know and What the New Zealand Data Say

New Zealand Economic Papers

English

Atherosclerosis and Lupus: What We Know and What We Should Know

Journal of Rheumatology

English